Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 10/20 10:14:59 pm
71.04 USD   +0.87%
10/19 EXPRESS SCRIPTS : Union fails to get enough votes among Express Scri..
10/06 EXPRESS SCRIPTS : execs work side by side with Jennings students
10/04 Express Scripts Holding Company Announces Third Quarter Earnings ..
News SummaryMost relevantAll newsSector news 

Express Scripts Holding Co : Express Scripts Sues Ernst & Young Alleging Document Theft

share with twitter share with LinkedIn share with facebook
share via e-mail
02/16/2013 | 12:36am CEST
   By Jon Kamp and Michael Rapoport 

Pharmacy-benefit giant Express Scripts Holding Co. (ESRX) has filed a lawsuit against accounting firm Ernst & Young LLP and a former employee for allegedly stealing at least 20,000 pages of data containing confidential information and trade secrets.

St. Louis-based Express Scripts hired E&Y to provide consulting services while combining its business with Medco Health Solutions. Express Scripts bought Medco last year to form the largest pharmacy-benefit manager by prescriptions handled.

These firms, known as PBMs, managed drug benefits for health plans and corporate clients, using their buying clout to secure rebates from drug manufacturers. Express Scripts said in the lawsuit that its investigation did not show E&Y's actions affecting any patient or protected health information.

But Express Scripts did accuse the big-four accounting giant of taking "competitively sensitive cost and pricing information" and "highly proprietary" documents involving business and integration strategies, projections and performance metrics.

Express Scripts didn't have a comment on the matter beyond the content of the court filing, which seeks "substantial punitive damages," and to stop E&Y from using or disclosing the information at issue. The lawsuit was filed Thursday in the Circuit Court in St. Louis County, Mo., and reviewed by Dow Jones Newswires.

E&Y in a statement Friday confirmed there was a violation of company policies, and that the individual "at the center of these allegations"--who the Express Scripts lawsuit said was a Health Care IT Partner named Donald Gravlin--"is no longer with the firm."

But E&Y also said it will "vigorously contest the claims" in the lawsuit. The accounting firm noted it "immediately took all necessary steps" to secure the data at issue once it became aware of the matter, and that it's not aware of any instance where the data was used inappropriately or transmitted to a third party.

According to Express Scripts' allegations, an investigation launched last August determined Mr. Gravlin was sending confidential information from another E&Y employee's Express Scripts email account to an outside email account. The company accused him of "sneaking into Express Scripts' headquarters and stealing confidential and proprietary information" for months.

The PBM also alleged that E&Y was motivated to facilitate this activity because it stood to gain from the confidential information, which could be used to grow and develop additional business both with Express Scripts and competitors.

Attempts to reach Mr. Gravlin late Friday were unsuccessful.

E&Y said it believes its prompt action to secure the data prevented any harm to Express Scripts. "Ernst & Young takes client confidentiality seriously," the company said. "We are fully committed to following our clients' security protocols."

Express Scripts uses PricewaterhouseCoopers for auditing work and Deloitte for tax accounting.

Write to Jon Kamp at jon.kamp@dowjones.com

Corrections & Amplifications

This was corrected at 7:47 p.m. EST because the original incorrectly identified the accounting firm in the last paragraph as PricewaterhouseCoopers. That firm does auditing work for Express Scripts, and the tax accountant is Deloitte.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
10/19 EXPRESS SCRIPTS : Union fails to get enough votes among Express Scripts employee..
10/19 EXPRESS SCRIPTS : 4th Source Sponsors 25th Reach for a Star Gala Benefitting Cys..
10/06 EXPRESS SCRIPTS : St. Louis IAM District 837 Launches Campaign to Bring 'Justice..
10/06 EXPRESS SCRIPTS : execs work side by side with Jennings students
10/04 Express Scripts Holding Company Announces Third Quarter Earnings Conference C..
10/04 EXPRESS SCRIPTS : Horizon Pharma, Express Scripts to Settle Rebate Litigation
10/02 INSIDER Q&A : A front-row seat for the drug pricing battle
09/29 Deductibles For Employer Healthcare Plans Soar, Kaiser Family Foundation Repo..
09/28 EXPRESS SCRIPTS : employees to vote on union representation
09/17 EXPRESS SCRIPTS : Launches Inflammatory Conditions Care Value Program(SM), Makin..
More news
Sector news : Drug Retailers - NEC
10/20DJWalgreens, Rite Aid Push Back Merger Deadline -- Update
10/20 Walgreens sees Rite Aid deal closing in early 2017
10/20DJWALGREENS BOOTS ALLIANCE : Rite Aid Push Back Merger Deadline
10/10DJWALGREENS BOOTS ALLIANCE : Major Investor Sues Theranos
10/06DJToday's Top Supply Chain and Logistics News From WSJ
More sector news : Drug Retailers - NEC
News from SeekingAlpha
10/11 Horizon Pharma sees Q3 sales of ~$208M and ~$960M for the year; shares off 6%..
10/10 Avoid Valeant Amid Philidor Debacle
09/22 Where Did All That EpiPen Money Go?
09/20 EXPRESS SCRIPTS : Avoid Business Cycle With Healthcare
09/19 WALGREENS BOOTS ALLIANCE : Buffett-Like Appeal
Financials ($)
Sales 2016 101 873 M
EBIT 2016 6 621 M
Net income 2016 2 887 M
Debt 2016 12 618 M
Yield 2016 -
P/E ratio 2016 15,64
P/E ratio 2017 14,06
EV / Sales 2016 0,56x
EV / Sales 2017 0,53x
Capitalization 44 771 M
More Financials
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 23
Average target price 81,3 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Senior Vice President-Operations
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-10.71%93 081
More Results